<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39498382</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Brain, behavior, &amp; immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>Clinical features and predictive nomogram for fatigue sequelae in non-severe patients infected with SARS-CoV-2 Omicron variant in Shanghai, China.</ArticleTitle><Pagination><StartPage>100889</StartPage><MedlinePgn>100889</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100889</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2024.100889</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Patients with coronavirus disease 2019(COVID-2019) infections may still experience long-term effects, with fatigue being one of the most frequent ones. Clinical research on the long COVID in the Chinese population after infection is comparatively lacking.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To collect and analyze the long-term effects of non-severe COVID-19 infection patients and to develop a model for the prediction of fatigue symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">223 non-severe COVID-19 patients admitted to one designated hospital were enrolled after finish all the self-designed clinical information registration form and nine-month follow-up. We explored the frequency and symptom types of long COVID. Correlation analysis was done on the neuropsychological scale results. After cluster analysis, lasoo regression and logistic regressions, a nomogram prediction model was produced as a result of investigating the risk factors for fatigue.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 108 (48.4%) of the 223 non-severe COVID-19 patients reported sequelae for more than 4 weeks, and of these, 35 (15.7%) had fatigue sequelae that were scale-confirmed. Other sequelae of more than 10% were brain fog (<i>n</i>&#xa0;=&#xa0;37,16.6%), cough (<i>n</i>&#xa0;=&#xa0;26,11.7%) and insomnia (n&#xa0;=&#xa0;23,10.3%). A correlation between depression and fatigue was discovered following the completion of neuropsychological scale. The duration of hospitalization, the non-use of antiviral medications in treatment, IL-6 and CD16+CD56<sup>+</sup> cell levels in blood are the main independent risk factors and predictors of fatigue sequelae in long COVID. Additionally, the neurology diseases and vaccination status may also influence the fatigue sequelae.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Nearly half of the patients infected with COVID-19 Omicron variant complained of sequelae, and fatigue was the most common symptom, which was correlated with depression. Significant predictors of fatigue sequelae included length of hospitalization, non-use of antiviral drug, and immune-related serum markers of IL-6 and CD16+CD56<sup>+</sup> NK cell levels. The presence of neurology diseases and a lack of vaccination could also predict the occurrence of fatigue sequelae.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Xiao-Lei</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yu-Han</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shen-Jie</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xin-Yi</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian-Ren</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID syndrome</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39498382</ArticleId><ArticleId IdType="pmc">PMC11532739</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2024.100889</ArticleId><ArticleId IdType="pii">S2666-3546(24)00167-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aghajani Mir M. Brain fog: a narrative review of the most common mysterious cognitive disorder in COVID-19. Mol. Neurobiol. Published online October 24, 2023. doi:10.1007/s12035-023-03715-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">37874482</ArticleId></ArticleIdList></Reference><Reference><Citation>Akova M., Unal S. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021;22(1):276. doi: 10.1186/s13063-021-05180-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05180-1</ArticleId><ArticleId IdType="pmc">PMC8042350</ArticleId><ArticleId IdType="pubmed">33849629</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Davis H., McCorkell L., et al. Long COVID science, research and policy. Nat Med. 2024;30(8):2148&#x2013;2164. doi: 10.1038/s41591-024-03173-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-03173-6</ArticleId><ArticleId IdType="pubmed">39122965</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker A.M.E., Maffitt N.J., Del Vecchio A., et al. Neural dysregulation in post-COVID fatigue. Brain Communications. 2023;5(3) doi: 10.1093/braincomms/fcad122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad122</ArticleId><ArticleId IdType="pmc">PMC10257363</ArticleId><ArticleId IdType="pubmed">37304792</ArticleId></ArticleIdList></Reference><Reference><Citation>Belayachi J., Obtel M., Mhayi A., Razine R., Abouqal R. Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco. Lau E.H.Y., editor. PLoS One. 2022;17(12) doi: 10.1371/journal.pone.0278546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278546</ArticleId><ArticleId IdType="pmc">PMC9728886</ArticleId><ArticleId IdType="pubmed">36477077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Version) Infectious Diseases &amp; Immunity. 2022;2(3):135&#x2013;144. doi: 10.1097/ID9.0000000000000059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ID9.0000000000000059</ArticleId><ArticleId IdType="pmc">PMC9295936</ArticleId><ArticleId IdType="pubmed">37520110</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Notarte K.I., Peligro P.J., et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14(12):2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Medicherla C., et al. Trajectories of neurologic recovery 12 Months after hospitalization for COVID-19: a prospective longitudinal study. Neurology. 2022;99(1):e33&#x2013;e45. doi: 10.1212/WNL.0000000000200356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200356</ArticleId><ArticleId IdType="pmc">PMC9259089</ArticleId><ArticleId IdType="pubmed">35314503</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattab D., Amer M.F.A., Al-Alami Z.M., Bakhtiar A. SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants. Infection. 2024;52(3):767&#x2013;786. doi: 10.1007/s15010-024-02223-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-024-02223-y</ArticleId><ArticleId IdType="pmc">PMC11143066</ArticleId><ArticleId IdType="pubmed">38554253</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J., Buck P., Zipfel S., Stengel A. Post-COVID-19 fatigue: a systematic review. Front Psychiatry. 2022;13 doi: 10.3389/fpsyt.2022.947973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType="pmc">PMC9403611</ArticleId><ArticleId IdType="pubmed">36032234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N., Dantzer R., Khandaker G.M. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 2021;131 doi: 10.1016/j.psyneuen.2021.105295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType="pmc">PMC8172271</ArticleId><ArticleId IdType="pubmed">34119855</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R., Soung A., Sissoko C., et al. COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis. Review. 2021 doi: 10.21203/rs.3.rs-1031824/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1031824/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong K., Chang Y., Qiao H., et al. Paxlovid accelerates cartilage degeneration and senescence through activating endoplasmic reticulum stress and interfering redox homeostasis. J. Transl. Med. 2022;20(1):549. doi: 10.1186/s12967-022-03770-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03770-4</ArticleId><ArticleId IdType="pmc">PMC9701426</ArticleId><ArticleId IdType="pubmed">36435786</ArticleId></ArticleIdList></Reference><Reference><Citation>Leaky blood&#x2013;brain barrier in long-COVID-associated brain fog. Nat. Neurosci. 2024;27(3):395&#x2013;396. doi: 10.1038/s41593-024-01577-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01577-8</ArticleId><ArticleId IdType="pubmed">38388737</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., et al. 2023. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Published online.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Machkovech H.M., Hahn A.M., Garonzik Wang J., et al. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect. Dis. 2024;24(7):e453&#x2013;e462. doi: 10.1016/S1473-3099(23)00815-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00815-0</ArticleId><ArticleId IdType="pubmed">38340735</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P., Michelutti M., Furlanis G., Deodato M., Buoite Stella A. Deficient GABABergic and glutamatergic excitability in the motor cortex of patients with long-COVID and cognitive impairment. Clin. Neurophysiol. 2023;151:83&#x2013;91. doi: 10.1016/j.clinph.2023.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2023.04.010</ArticleId><ArticleId IdType="pmc">PMC10170904</ArticleId><ArticleId IdType="pubmed">37210757</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcocci M.E., Napoletani G., Protto V., et al. Herpes simplex virus-1 in the brain: the dark side of a sneaky infection. Trends Microbiol. 2020;28(10):808&#x2013;820. doi: 10.1016/j.tim.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.03.003</ArticleId><ArticleId IdType="pubmed">32386801</ArticleId></ArticleIdList></Reference><Reference><Citation>Marogianni C., Sokratous M., Dardiotis E., Hadjigeorgiou G.M., Bogdanos D., Xiromerisiou G. Neurodegeneration and inflammation&#x2014;an interesting interplay in Parkinson's disease. IJMS. 2020;21(22):8421. doi: 10.3390/ijms21228421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228421</ArticleId><ArticleId IdType="pmc">PMC7697354</ArticleId><ArticleId IdType="pubmed">33182554</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzolini C., Kuritzkes D.R., Marra F., et al. Recommendations for the management of drug&#x2013;drug interactions between the COVID 19 antiviral nirmatrelvir/ritonavir (Paxlovid) and comedications. Clin Pharma and Therapeutics. 2022;112(6):1191&#x2013;1200. doi: 10.1002/cpt.2646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2646</ArticleId><ArticleId IdType="pmc">PMC9348462</ArticleId><ArticleId IdType="pubmed">35567754</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurkiewicz I., Chatys Bogacka Z., Slowik J., et al. Fatigue after COVID 19 in non hospitalized patients according to sex. Brain and Behavior. 2023;13(2) doi: 10.1002/brb3.2849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2849</ArticleId><ArticleId IdType="pmc">PMC9927850</ArticleId><ArticleId IdType="pubmed">36620918</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S., Jagannathan P., Henrich T.J., et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12 doi: 10.7554/eLife.86014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86014</ArticleId><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Morriss R., Wearden A., Mullis R. Exploring the validity of the chalder fatigue scale in chronic fatigue syndrome. J. Psychosom. Res. 1998;45(5):411&#x2013;417. doi: 10.1016/S0022-3999(98)00022-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(98)00022-1</ArticleId><ArticleId IdType="pubmed">9835234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P., Ferrazzoli D., Sebastianelli L., et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: insights into a challenging symptom. J. Neurol. Sci. 2021;420 doi: 10.1016/j.jns.2020.117271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117271</ArticleId><ArticleId IdType="pmc">PMC7834526</ArticleId><ArticleId IdType="pubmed">33359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P., Ferrazzoli D., Sebastianelli L., et al. Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID&#x2010;19. Euro J of Neurology. 2022;29(6):1652&#x2013;1662. doi: 10.1111/ene.15278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15278</ArticleId><ArticleId IdType="pmc">PMC9111319</ArticleId><ArticleId IdType="pubmed">35138693</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman M.S., Van Eeden C., Cohen Tervaert J.W. Fatal COVID-19 infections: is NK cell dysfunction a link with autoimmune HLH? Autoimmun. Rev. 2020;19(7) doi: 10.1016/j.autrev.2020.102561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102561</ArticleId><ArticleId IdType="pmc">PMC7252043</ArticleId><ArticleId IdType="pubmed">32376401</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Al-Ahmed S.H., Garout M.A., et al. Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses. Pathogens. 2021;10(5):565. doi: 10.3390/pathogens10050565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10050565</ArticleId><ArticleId IdType="pmc">PMC8150955</ArticleId><ArticleId IdType="pubmed">34066983</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina J., Iglesias C. Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination. Rev Esp Quimioter. 2022;35(3):236&#x2013;240. doi: 10.37201/req/002.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.37201/req/002.2022</ArticleId><ArticleId IdType="pmc">PMC9134883</ArticleId><ArticleId IdType="pubmed">35183067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect. Dis. 2021;8(10):ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Saqib K., Goel V., Dubin J.A., VanderDoes J., Butt Z.A. Exploring the syndemic impact of COVID-19 and mental health on health services utilisation among adult Ontario population. Publ. Health. 2024;236:70&#x2013;77. doi: 10.1016/j.puhe.2024.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2024.07.008</ArticleId><ArticleId IdType="pubmed">39168036</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Reports Medicine. 2022;3(6) doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X., Wang P., Shen J., et al. Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China. Journal of Infection and Public Health. 2023;16(2):155&#x2013;162. doi: 10.1016/j.jiph.2022.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.12.005</ArticleId><ArticleId IdType="pmc">PMC9726211</ArticleId><ArticleId IdType="pubmed">36535135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B. RECOVER Mechanistic Pathway Task Force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12 doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long&#x2010;COVID syndrome&#x2010;associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47(2):232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., et al. In: Madeddu G., editor. vol. 15. 2020. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. (PLoS ONE).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Feltz-Cornelis C., Turk F., Sweetman J., et al. Prevalence of mental health conditions and brain fog in people with long COVID: a systematic review and meta-analysis. Gen. Hosp. Psychiatr. 2024;88:10&#x2013;22. doi: 10.1016/j.genhosppsych.2024.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2024.02.009</ArticleId><ArticleId IdType="pubmed">38447388</ArticleId></ArticleIdList></Reference><Reference><Citation>Varchetta S., Mele D., Oliviero B., et al. Unique immunological profile in patients with COVID-19. Cell. Mol. Immunol. 2021;18(3):604&#x2013;612. doi: 10.1038/s41423-020-00557-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00557-9</ArticleId><ArticleId IdType="pmc">PMC7557230</ArticleId><ArticleId IdType="pubmed">33060840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhao D., Xiao W., et al. Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge. J. Med. Virol. 2023;95(8) doi: 10.1002/jmv.29014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29014</ArticleId><ArticleId IdType="pubmed">37522243</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski M., Tizian C., Ferreira-Gomes M., et al. Untimely TGF&#x3b2; responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600(7888):295&#x2013;301. doi: 10.1038/s41586-021-04142-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04142-6</ArticleId><ArticleId IdType="pubmed">34695836</ArticleId></ArticleIdList></Reference><Reference><Citation>xin Zhan Y., yu Zhao S., Yuan J., et al. Prevalence and influencing factors on fatigue of first-line nurses combating with COVID-19 in China: a descriptive cross-sectional study. CURR MED SCI. 2020;40(4):625&#x2013;635. doi: 10.1007/s11596-020-2226-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-020-2226-9</ArticleId><ArticleId IdType="pmc">PMC7412774</ArticleId><ArticleId IdType="pubmed">32767264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post&#x2010;COVID&#x2010;19 syndrome (or long&#x2010;COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32(4) doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Zuo Y., Jiang L., Peng Y., Huang X., Zuo L. Epstein-barr virus and neurological diseases. Front. Mol. Biosci. 2022;8 doi: 10.3389/fmolb.2021.816098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.816098</ArticleId><ArticleId IdType="pmc">PMC8784775</ArticleId><ArticleId IdType="pubmed">35083281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Cooper-Knock J., Weimer A.K., et al. Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity. Cell Systems. 2022;13(8):598&#x2013;614.e6. doi: 10.1016/j.cels.2022.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2022.05.007</ArticleId><ArticleId IdType="pmc">PMC9163145</ArticleId><ArticleId IdType="pubmed">35690068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Shibata K., Hellyer P.J., et al. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Communications. 2022;4(1) doi: 10.1093/braincomms/fcab295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab295</ArticleId><ArticleId IdType="pmc">PMC8807287</ArticleId><ArticleId IdType="pubmed">35128398</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>